| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.11 | 0.6 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.11 | 0.6 |